Cargando…

Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer

Heparanase (HPSE), an endoglycosidase that cleaves heparan sulfate, regulates a variety of biological processes that promote tumor progression. In this study, we analyzed the correlation between HPSE expression and prognosis in cancer patients, using multiple databases (Oncomine, TIMER, PrognoScan,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Wen-Jing, Shi, Lin, Wang, Xiao-Min, Yang, Guo-Wang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436937/ https://www.ncbi.nlm.nih.gov/pubmed/34461608 http://dx.doi.org/10.18632/aging.203489

Ejemplares similares

Heparanase from triple-negative breast cancer and platelets acts as an enhancer of metastasis
por: Yang, Wen-Jing, et al.
Publicado: (2020)

TILRR (FREM1 isoform 2) is a prognostic biomarker correlated with immune infiltration in breast cancer
por: Xu, Xiao-Yi, et al.
Publicado: (2020)

Elemene inhibits the migration and invasion of 4T1 murine breast cancer cells via heparanase
por: Zhang, Yi, et al.
Publicado: (2017)

HNRNPA2B1 is a potential biomarker of breast cancer related to prognosis and immune infiltration
por: Ayoufu, Aisikeer, et al.
Publicado: (2023)

CD1C is associated with breast cancer prognosis and immune infiltrates
por: Chen, Xiao, et al.
Publicado: (2023)

ADPRH is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma
por: Zhang, Chunyu, et al.
Publicado: (2021)

EPHA3 Could Be a Novel Prognosis Biomarker and Correlates with Immune Infiltrates in Bladder Cancer
por: Liu, Junpeng, et al.
Publicado: (2023)

Heparanase augments insulin receptor signaling in breast carcinoma
por: Goldberg, Rachel, et al.
Publicado: (2016)

Salmonella alters heparanase expression and reduces tumor metastasis
por: Chiu, Huan-Min, et al.
Publicado: (2021)

PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer PPAR-δ as a prognostic biomarker and its association with immune infiltrates in breast cancer
por: Wang, Zonghan, et al.
Publicado: (2023)

An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
por: Sui, Silei, et al.
Publicado: (2020)

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer
por: Liang, Yuan-ke, et al.
Publicado: (2021)

Infiltrating Immune Cells in Gastric Cancer: A Novel Predicting Model for Prognosis
por: Li, Wenjie, et al.
Publicado: (2021)

Immune-infiltration based signature as a novel prognostic biomarker in gastrointestinal stromal tumour
por: Wei, Zhe-Wei, et al.
Publicado: (2020)

Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data
por: Sun, Xu, et al.
Publicado: (2017)

Insights into prognosis and immune infiltration of cuproptosis-related genes in breast cancer
por: Huang, Tingting, et al.
Publicado: (2022)

Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
por: Zahavi, Tamar, et al.
Publicado: (2021)

Prognostic significance of heparanase expression in primary and metastatic breast carcinoma
por: Vornicova, Olga, et al.
Publicado: (2017)

Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer
por: Yang, Xi, et al.
Publicado: (2021)

Hypermethylation of heparanase 2 promotes colorectal cancer proliferation and is associated with poor prognosis
por: Zhang, Hui, et al.
Publicado: (2021)

A novel pyroptosis-related indicator of immune infiltration features and prognosis in breast cancer
por: Wang, Cheng, et al.
Publicado: (2022)

Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration
por: Lei, Yuanyuan, et al.
Publicado: (2021)

Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T-lymphocytes
por: Caruana, Ignazio, et al.
Publicado: (2015)

Chordin-like 1 is a novel prognostic biomarker and correlative with immune cell infiltration in lung adenocarcinoma
por: Deng, Bing, et al.
Publicado: (2022)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

Clinical Implications of Tumor-Infiltrating Immune Cells in Breast Cancer
por: Zhang, Shi-Chao, et al.
Publicado: (2019)

Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker
por: Chen, Wu, et al.
Publicado: (2023)

APOE Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Papillary Thyroid Carcinoma
por: Lin, Xu, et al.
Publicado: (2022)

Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012)

SART3, regulated by p53, is a biomarker for diagnosis, prognosis and immune infiltration in hepatocellular carcinoma
por: Nong, Jusen, et al.
Publicado: (2023)

Gubenyiliu II Inhibits Breast Tumor Growth and Metastasis Associated with Decreased Heparanase Expression and Phosphorylation of ERK and AKT Pathways
por: Zhang, Yi, et al.
Publicado: (2017)

Immune cell infiltration as a biomarker for the diagnosis and prognosis of digestive system cancer
por: Yang, Sheng, et al.
Publicado: (2019)

Ceruloplasmin correlates with immune infiltration and serves as a prognostic biomarker in breast cancer
por: Chen, Fei, et al.
Publicado: (2021)

ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma
por: Lin, Xu, et al.
Publicado: (2021)

Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma
por: Li, Tian-Hao, et al.
Publicado: (2021)

Identification of an exosome-related signature associated with prognosis and immune infiltration in breast cancer
por: Guo, Qiaonan, et al.
Publicado: (2023)

Identification of STAT5B as a biomarker associated with prognosis and immune infiltration in breast cancer
por: Li, Jiaying, et al.
Publicado: (2023)

Association of Enolase-1 with Prognosis and Immune Infiltration in Breast Cancer by Clinical Stage
por: Shi, Yue-Yu, et al.
Publicado: (2023)

Heparanase and the hallmarks of cancer
por: Jayatilleke, Krishnath M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lrajt0tcl9ua04p0j3hgebh014